Enterprises looking to collaborate on the cutting-edge of biotechnology are finding their way to CBIS. In operation since 2004, CBIS offers the most advanced biotechnology research facility in the nation. What sets us apart is our collaborative, interdisciplinary focus. We are a hub for industry, academia, federal government, and associations to work cooperatively on transformative innovations in biotechnology at the interface of life sciences, physical sciences and engineering. Our interdisciplinary research teams perform fundamental, applied, and translational research. CBIS is a powerhouse of basic research and its application to solving real-world problems in healthcare and biotechnology.
Partnerships with Industry
Collaboration through NIIMBL
CBIS is a member of the National Institute for Innovation in Manufacturing Biopharmaceuticals. We are developing new methodologies in Advanced Manufacturing of Biotechnology diagnostic and therapeutic technologies. We are very excited to collaborate with industry, academia, non-profit organizations, and federal agencies. We are making strides in developing rapid, flexible, and cost-efficient biopharmaceutical manufacturing technologies.
Collaborative Center for Research Innovation and Entrepreneurship
CBIS has a long-standing relationship with the The Icahn School of Medicine at Mount Sinai School of Medicine (ISMMS) which began as a research collaboration and now encompasses both research and education. The Mount Sinai and Rensselaer Collaborative Center for Research Innovation and Entrepreneurship is the hub for these joint efforts, with the Mount Sinai Institute of Technology (MSIT) functioning as the primary partnership locus at Mount Sinai. Complementary research programs involving Mount Sinai and RPI investigators address a broad range of conditions in such diverse areas as neuroscience and neurological diseases, genomics, imaging, orthopedics, cancer, and cardiovascular disease.
For information contact: